AmpTec

Hamburg, Germany Founded: 2005 • Age: 21 yrs Acquired By Merck
Provider of products for RNA biology
Request Access

About AmpTec

AmpTec is a company based in Hamburg (Germany) founded in 2005 by Guido Krupp and Peter Scheinert was acquired by Merck in January 2021.. AmpTec operates in a competitive market with competitors including ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others.

  • Headquarter Hamburg, Germany
  • Founders Guido Krupp, Peter Scheinert
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $40.51 K (USD), Grant

    Dec 10, 2021

  • Investors
    Merck

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Merck

    (Jan 07, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of AmpTec

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $40,511
  • First Round

    (06 Mar 2020)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2021 Amount Grant - AmpTec Valuation

investors

Feb, 2021 Amount Grant - AmpTec Valuation

investors

Mar, 2020 Amount Grant - AmpTec Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AmpTec

AmpTec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Merck and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Merck is engaged in science and technology solutions globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AmpTec

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AmpTec

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Amptec Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AmpTec

AmpTec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Speech recognition solutions are provided by Inscripta for healthcare professionals.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Genomic and theranostic services for oncology precision medicine are delivered.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Develops tools and products for research and clinical application
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Amptec

Frequently Asked Questions about AmpTec

When was AmpTec founded?

AmpTec was founded in 2005 and raised its 1st funding round 15 years after it was founded.

Where is AmpTec located?

AmpTec is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.

Who is the current CEO of AmpTec?

Peter Scheinert is the current CEO of AmpTec. They have also founded this company.

What does AmpTec do?

AmpTec was founded in 2005 and is based in Hamburg, Germany. Operations focus on the biotechnology sector, where RNA isolation kits, mRNA amplification kits, guide RNAs for CRISPR applications, synthetic long RNAs and DNAs, and functional mRNAs are developed and distributed. The portfolio supports research in RNA-related fields through these specialized offerings.

Who are the top competitors of AmpTec?

AmpTec's top competitors include Sino Biological, OncoDNA and ArcherDX.

Who are AmpTec's investors?

AmpTec has 2 investors. Key investors include Merck, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available